Trauma Devices – Market Insights – Japan

The impact of the COVID-19 pandemic on the Japanese trauma device market was relatively lesser due to the urgent nature of the procedures involved. Going forward, market growth will be supported by favorable demographics and the increasing presence of domestic competitors. However, certain factors, such as the potential implementation of a reimbursement pricing system based on cost-effectiveness, slower introduction of high-priced devices compared to other mature global markets, and declining average selling prices due to biennial reimbursement cuts by the MHLW, will pose challenges to overall market growth.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for trauma devices in Japan from 2019 through 2032.

The trauma device market was quick to recover from the COVID-19 pandemic.

How much has the trauma market recovered from the effects of the COVID-19 pandemic?

When will each segment of the market return to levels seen prior to the pandemic?

MNCs have established a strong presence and hold a significant share in the Japanese trauma device market.

Which MNCs have the strongest presence in the Japanese market?

What strategies and factors will contribute to success in this region through 2032?

The Japanese trauma device market will continue to be adversely affected by the biennial reimbursement cuts implemented by the MHLW.

Which segments will be most severely impacted by MHLW reimbursement cuts?

What strategies will companies use to increase their market share despite reimbursement cuts in the Japanese trauma device market?

The Japanese market possesses unique dynamics that make it different from trauma device markets in other countries or regions.

What market drivers and limiters are unique to Japan, and how are these factors affecting the various market segments?

How should manufacturers respond to these market forces to bolster their positions in the Japanese trauma device market?

Which device segments are growing the fastest, and why?

Which device segments are seeing declines, and what is contributing to this?

Several manufacturers have recently expanded their product portfolios with the introduction of new devices or by acquiring companies with complementary products.

Which competitors are using the breadth of their product portfolios to sustain or increase their trauma device market shares?

How are competitors expanding their offerings through product innovation, mergers, acquisitions, and/or partnerships to capture a larger share of the trauma device market?

Despite the complexities of the regulatory environment, certain competitors in the Japanese market possess advantages either through their understanding of the local market or by capitalizing on their success in other markets.

Which competitors are best poised for success going forward?

How does the regulatory system affect current and future market revenues for companies in this space?

Table of contents